Showing results (41-50 of 54) with videos related to

Sort By:
Pageof 6
Immunotherapy|February 11, 2017
A pilot study of peripheral blood BDCA-1 (CD1c) positive dendritic cells pulsed with NY-ESO-1 ISCOMATRIX™ adjuvantIan D Davis, Juliet Quirk, Leone Morris, et al.
Med (New York, N.Y.)|February 7, 2022
Antiviral metabolite 3'-deoxy-3',4'-didehydro-cytidine is detectable in serum and identifies acute viral infections including COVID-19Ravi Mehta, Elena Chekmeneva, Heather Jackson, et al.
Cancer Immunity|July 17, 2003
Two phase I studies of low dose recombinant human IL-12 with Melan-A and influenza peptides in subjects with advanced malignant melanomaJonathan Cebon, Elke Jäger, Mark J Shackleton, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|September 15, 2006
Blood dendritic cells generated with Flt3 ligand and CD40 ligand prime CD8+ T cells efficiently in cancer patientsIan D Davis, Qiyuan Chen, Leone Morris, et al.
Frontiers in Psychiatry|October 5, 2023
Naturalistic psilocybin use is associated with persisting improvements in mental health and wellbeing: results from a prospective, longitudinal surveySandeep M Nayak, Hillary Jackson, Nathan D Sepeda, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 16, 2004
Immunodominant CD4+ responses identified in a patient vaccinated with full-length NY-ESO-1 formulated with ISCOMATRIX adjuvantQiyuan Chen, Heather Jackson, Phillip Parente, et al.
International Journal of Molecular Sciences|June 2, 2021
Kawasaki Disease Patient Stratification and Pathway Analysis Based on Host Transcriptomic and Proteomic ProfilesHeather Jackson, Stephanie Menikou, Shea Hamilton, et al.
Scientific Reports|November 29, 2019
Plasma lipid profiles discriminate bacterial from viral infection in febrile childrenXinzhu Wang, Ruud Nijman, Stephane Camuzeaux, et al.
Scientific Reports|July 17, 2022
Characterisation of the blood RNA host response underpinning severity in COVID-19 patientsHeather Jackson, Irene Rivero Calle, Claire Broderick, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 15, 2004
Recombinant NY-ESO-1 protein with ISCOMATRIX adjuvant induces broad integrated antibody and CD4(+) and CD8(+) T cell responses in humansIan D Davis, Weisan Chen, Heather Jackson, et al.
Pageof 6